Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00277-024-05774-0.pdf
Reference26 articles.
1. Bar M, Sandmaier BM, Inamoto Y et al (2013) Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant 19(6):949–957. https://doi.org/10.1016/j.bbmt.2013.03.001
2. Kekre N, Kim HT, Thanarajasingam G et al (2015) Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation. Haematologica 100(9):1222–1227. https://doi.org/10.3324/haematol.2015.129650
3. Chang YJ, Huang XJ (2013) Donor lymphocyte infusions for relapse after allogeneic transplantation: when, if and for whom? Blood Rev 27(1):55–62. https://doi.org/10.1016/j.blre.2012.11.002
4. Liberio N, Robinson H, Nugent M et al (2019) Single-center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia. Pediatr Blood Cancer 66(11):e27950. https://doi.org/10.1002/pbc.27950
5. Ciurea SO, Kongtim P, Soebbing D et al (2022) Decrease post-transplant relapse using donor-derived expanded NK-cells. Leukemia 36(1):155–164. https://doi.org/10.1038/s41375-021-01349-4
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3